More

    Finance

    Carter's Inc. outlook revised to negative at S&P on declining profitability

    https://www.investing.com/news/stock-market-news/carters-inc-outlook-revised-to-negative-at-sp-on-declining-profitability-93CH-4076209 Investing.com

    SEC clears Hotel101 for Nasdaq listing via JVSPAC merger

    https://www.investing.com/news/company-news/sec-clears-hotel101-for-nasdaq-listing-via-jvspac-merger-93CH-4076159 Investing.com

    defi technologies appoints manfred knof as chairman of valour

    https://www.investing.com/news/sec-filings/defi-technologies-appoints-manfred-knof-as-chairman-of-valour-93CH-4076160 Investing.com

    BlackRock discloses stake in Mural Oncology

    https://www.investing.com/news/company-news/blackrock-discloses-stake-in-mural-oncology-93CH-4076161 Investing.com

    Embecta stock hits 52-week low at $10.26 amid market challenges

    https://www.investing.com/news/company-news/embecta-stock-hits-52week-low-at-1026-amid-market-challenges-93CH-4076068 Investing.com

    EJH stock touches 52-week low at $3.4 amid steep annual decline

    https://www.investing.com/news/company-news/ejh-stock-touches-52week-low-at-34-amid-steep-annual-decline-93CH-4076072 Investing.com

    Sylvamo stock hits 52-week low at $51.55 amid market challenges

    https://www.investing.com/news/company-news/sylvamo-stock-hits-52week-low-at-5155-amid-market-challenges-93CH-4076073 Investing.com

    trevi therapeutics reports positive results from phase 2b cough trial

    https://www.investing.com/news/sec-filings/trevi-therapeutics-reports-positive-results-from-phase-2b-cough-trial-93CH-4075947 Investing.com

    Latest articles

    spot_imgspot_img